Subscribe to RSS
DOI: 10.1055/s-2003-38477
© Georg Thieme Verlag Stuttgart · New York
Studies on the Antioxidative Activity of Phloroglucinol Derivatives Isolated from Hypericum Species
Publication History
Received: June 26, 2002
Accepted: October 20, 2002
Publication Date:
04 April 2003 (online)
Abstract
Twenty-one phloroglucinol derivatives, belonging to 8 different carbon skeletons, were tested for their ability to influence the oxidative burst of polymorphonuclear cells (PMNs) after stimulation with N-formyl-methionyl-leucyl-phenylalanine (FMLP) or opsonized zymosan (OZ). Results revealed a strong reduction of oxygen production by PMNs after stimulation with FMLP for the compounds ialibinone E (5), hyperguinone B (15) and hyperforin (21). The IC50 values obtained were 2.5 μM (5), 3.3 μM (15) and 1.8 μM (21), respectively. Slight modifications of the substituents or variation of the stereochemistry resulted in a significant loss of activity. None of the active compounds showed antioxidative activity after stimulation with OZ. The influence of compounds 5, 15 and 21 on the production of oxygen radicals in an H2O2/horseradish peroxidase system was investigated and revealed potent activity only for compound 5 (IC50 1 μM). The superoxide-scavenging properties of ialibinone E (5) and hyperguinone B (15) were additionally tested in a cytochrome c assay and only ialibinone E (5) was found to be significantly active at lower micromolar concentrations. Ialibinone E (5) was not active in a xanthine oxidase assay (urate formation) in concentrations up to 100 μM and its activity is therefore not attributable to the inhibition of this enzyme. It can be assumed that the activity of compounds 5 and 15 in the different cellular and enzymatic assays, is most likely caused by different and maybe specific mechanisms and cannot be explained by a radical scavenger activity alone. None of the active phloroglucinols showed cytotoxic effects against the PMNs.
Key words
Phloroglucinols - Hypericum - clusiaceae - antioxidative activity - reactive oxygen species
References
- 1 Aruoma O I. Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol. 1994; 32 671-83
- 2 Ames B N, Shigenaga M K, Hagen T M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993; 90 7915-22
- 3 Heilmann J, Çalis I, Kirmizbekmez H, Schühly W, Harput S, Sticher O. Radical scavenger activity of phenylethanoid glycosides in FMLP stimulated human polymorphonuclear leukocytes - structures activity relationships. Planta Med. 2000; 66 746-8
- 4 Limasset B, Le Doucen C, Dore J C, Ojasoo T, Damon M, DePaulet A C. Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Biochem Pharmacol. 1993; 46 1257-71
- 5 Rice-Evans C A, Miller N J, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med. 1996; 20 933-56
- 6 Sang S, Pan M-H, Cheng X, Bai N, Stark R E, Rosen R T, Lin-Shiau S-Y, Lin J-K, Ho C-T. Chemical studies on antioxidant mechanism of garcinol: analysis of radical reaction products of garcinol and their antitumor activities. Tetrahedron. 2001; 57 9931-8
- 7 Afannas’ev I B, Dorozhko A V, Brodskii V A, Kostyuk V A, Potapovitch A I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol. 1989; 38 1763-9
- 8 Winkelmann K, Heilmann J, Zerbe O, Rali T, Sticher O. New phloroglucinol derivatives from Hypericum papuanum . J Nat Prod. 2000; 63 104-8
- 9 Winkelmann K, Heilmann J, Zerbe O, Rali T, Sticher O. New prenylated bi- and tricyclic phloroglucinol derivatives from Hypericum papuanum . J Nat Prod. 2001; 64 701-6
- 10 Winkelmann K, Heilmann J, Zerbe O, Rali T, Sticher O. Further prenylated bi- and tricyclic phloroglucinol derivatives from Hypericum papuanum . Helv Chim Acta. 2001; 84 3380-92
- 11 Walker B AM, Hagenlocker B E, Stubbs E B, Sandborg R R, Agranoff B W, Ward P A. Signal transduction events and FcγR engagement in human neutrophils stimulated with immune complexes. J Immunol. 1991; 146 735-41
- 12 Fantone J C, Ward P A. Role of oxygen derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982; 107 397-418
- 13 Hazan-Halevy I, Seger R, Levy R. The requirement of both extracellular regulate kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A2 activity by either FcγRIIA or FcγRIIIB in human neutrophils. J Biol Chem. 2000; 275 12416-23
- 14 Hazan I, Dana R, Granot Y, Levy R. Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Biochem J. 1997; 326 867-76
- 15 Takahashi R, Edashige K, Sato E F, Inoue M, Matsuno T, Utsumi K. Luminol chemiluminescence and active oxygen generation by activated neutrophils. Arch Biochem Biophys. 1991; 285 325-30
- 16 Namgaladze D, Hofer H W, Ullrich V. Redox control of calcineurin by targeting the binuclear Fe2+-Zn2+ center at the enzyme active site. J Biol Chem. 2002; 277 5962-9
- 17 Heilmann J, Merfort I, Weiss M. Radical scavenger activity of different 3′,4′-dihydroxy-flavonols and 1,5-dicaffeoylquinic acid studied by inhibition of chemiluminescence. Planta Med. 1995; 61 435-8
- 18 Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C. Radical scavenger activity of three flavonoid metabolites studies by inhibition of chemiluminescence in human PMNs. Planta Med. 1996; 62 289-92
- 19 Lobitz G O, Heilmann J, Zschocke S, Tamayo-Castillo G, Bauer R, Merfort I. Bornyl cinnamate derivatives with anti-inflammatory activity from Verbesina turbacensis . Pharm Pharmacol Lett. 1988; 8 115-8
- 20 Fridovich I. Quantitative aspects of the production of superoxide anion radicals by milk xanthine oxidase. J Biol Chem. 1970; 245 4053-7
- 21 Orth H CJ, Rentel C, Schmidt P C. Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L. J Pharm Pharmacol. 1999; 51 193-200
PD. Dr. Jörg Heilmann
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology (ETH) Zurich
Winterthurerstr. 190
8057 Zürich
Switzerland
Phone: +41-1-635-6049
Fax: +41-1-635-6882
Email: joerg.heilmann@pharma.anbi.ethz.ch